DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 11 II, 1998, Pages 2178-2181

  Ammirati, Fabrizio ^a   Colivicchi, Furio ^a   Toscano, Salvatore ^a   Pandozi, Claudio ^a   Laudadio, Maria Teresa ^b   De Seta, Francesco ^b   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b Medtronic Italia   (Italy)

Author keywords

Pacemaker therapy; Vasovagal syncope

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETILEFRINE;

ADULT; AGED; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD TILTING; HUMAN; MALE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYNCOPE;

EID: 0031725060     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb01148.x     Document Type: Review

References (17)

1. Fitzpatrick AP, Ahmed R, Williams S, et al. A randomised trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia/hypotension syndrome. Eur JCPE 1991; 1:198-202.
2. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70:339-342.
3. Morillo CA, Leitch JU, Yee R, et al. A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22:1843-1848.
4. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J. Limitation of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilephrine versus placebo. J Am Coll Cardiol 1995; 25:65-69.
5. Fitzpatrick AP, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degree tilt. PACE 199; 13:13-19.
6. Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur JCPE 1993; 1:36-41.
7. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328:1085-1090.
8. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71:274-281.
9. Gammage MD, Hess M, Markowitz T. Initial experience with rate drop algorithm in malignant vasovagal syncope. Eur JCPE 1995; 5:45-48.
10. Benditt D, Sutton R, Gammage MD, et al. Clinical experience with Thera DR rate-drop response algorithm in carotid sinus syndrome and vaso-vagal syncope. PACE 1997; 20:832-839.
11. Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope Eur JCPE 1992; 3:180-183.
12. Fitzpatrick AP, Theodorakis G, Vardas P, et al. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17:125-130.
13. Kapoor WN. Work-up and management of patients with syncope. Clin Med North Am 1995; 79: 1153-1170.
14. Benditt D. Neurally mediated syncopal syndromes: Pathophysiological concepts and clinical evaluation. PACE 1997; 20:572-584.
15. Petersen MEV, Sutton R. Cardiac pacing for vasovagal syncope : A reasonable therapeutic option? PACE 1997; 20:825-826.
16. Sheldon RS, Rose S, Flanagan P, et al. Multivariate predictors of syncope recurrence in drug-free patients following a positive tilt table test . Circulation 1996; 93:973-981.
17. Grubb BP, Kosinski D. Tilt table testing: Concepts and limitations. PACE 1997; 20:781-787.